We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

143 hedge funds and large institutions have $379M invested in iShares US Pharmaceuticals ETF in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 50 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

4% more funds holding

Funds holding: 137 → 143 (+6)

10% less capital invested

Capital invested by funds: $422M → $379M (-$42.3M)

36% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 50

146.55% less ownership

Funds ownership: 204.27% → 57.71% (-147%)

Holders
143
Holders Change
+6
Holders Change %
+4.38%
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
23
Increased
32
Reduced
50
Closed
14
Calls
$367K
Puts
–
Net Calls
+$367K
Net Calls Change
+$366K

Top Buyers

1
AWM
Accurate Wealth Management
Florida
+$7.72M
2
VCM
Virtue Capital Management
Tennessee
+$5.13M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3M
4
SCA
Southern Capital Advisors
Tennessee
+$2.57M
5
MFG
Merit Financial Group
Georgia
+$2.06M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$50.6M
2
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$11.4M
3
TRCT
Tower Research Capital (TRC)
New York
-$8.17M
4
RIG
RiverFront Investment Group
Virginia
-$7.02M
5
Fisher Asset Management
Fisher Asset Management
Washington
-$5.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fisher Asset Management
1
Fisher Asset Management
Washington
$240M -$5.63M -85,180 -2%
Morgan Stanley
2
Morgan Stanley
New York
$23.9M -$50.6M -764,761 -68%
Bank of America
3
Bank of America
North Carolina
$11.2M -$2.37M -35,902 -18%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$7.46M -$618K -9,350 -8%
AWM
5
Accurate Wealth Management
Florida
$7.36M +$7.72M +116,854 New
Brown Advisory
6
Brown Advisory
Maryland
$6.59M – – –
VCM
7
Virtue Capital Management
Tennessee
$4.98M +$5.13M +77,546 New
LPL Financial
8
LPL Financial
California
$4.51M -$272K -4,115 -6%
Wells Fargo
9
Wells Fargo
California
$4.26M -$169K -2,553 -4%
CIC
10
Concord Investment Counsel
California
$3.88M +$3.78M +57,145 New
RJA
11
Raymond James & Associates
Florida
$3.62M -$5.2M -78,605 -60%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$3.08M +$3M +45,398 New
PGFC
13
Peapack-Gladstone Financial Corp
New Jersey
$3.01M -$99.8K -1,510 -3%
Citadel Advisors
14
Citadel Advisors
Florida
$2.95M -$3.02M -45,732 -51%
SCA
15
Southern Capital Advisors
Tennessee
$2.64M +$2.57M +38,884 New
UBS Group
16
UBS Group
Switzerland
$2.6M -$320K -4,837 -11%
Commonwealth Equity Services
17
Commonwealth Equity Services
Massachusetts
$2.42M -$97.6K -1,476 -4%
MFG
18
Merit Financial Group
Georgia
$2.01M +$2.06M +31,191 New
OCM
19
One Capital Management
California
$1.84M -$33K -499 -2%
Mariner
20
Mariner
Kansas
$1.82M -$85.8K -1,298 -5%
Thrivent Financial for Lutherans
21
Thrivent Financial for Lutherans
Minnesota
$1.63M +$177K +2,672 +13%
KDA
22
Kraft Davis & Associates
Missouri
$1.59M -$616K -9,324 -28%
CFA
23
Cahill Financial Advisors
Minnesota
$1.43M +$2.45K +37 +0.2%
BPA
24
Beacon Pointe Advisors
California
$1.26M – – –
PP
25
Patten & Patten
Tennessee
$1.15M -$20.8K -315 -2%
1
2 3 4 5

IHE Hedge Fund Activity: Q1 2024 in Review

143 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q1 2024, worth a combined $379M — down 10% from $422M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new IHE positions and 14 closed out — a net gain of 9 holders — while 32 added to existing stakes and 50 trimmed.

The largest buyer was Accurate Wealth Management, opening a new position worth an estimated $7.72M. The largest seller was Morgan Stanley, cutting an estimated $50.6M.

  • 143 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q1 2024, up from 137 in Q4 2023.
  • Funds reported $379M of iShares US Pharmaceuticals ETF stock for Q1 2024, down 10% quarter-over-quarter.
  • 23 funds opened new iShares US Pharmaceuticals ETF positions in Q1 2024 and 14 closed out, a net change of +9 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q1 2024 was Accurate Wealth Management, an estimated $7.72M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q1 2024 was Morgan Stanley, an estimated $50.6M sold.

Based on aggregated 13F filings for Q1 2024.